Cargando…
Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second leading cause of cancer mortality worldwide. The cornerstone to improving the prognosis of HCC patients has been the control of loco-regional disease progression and the lesser toxicities of local treatment. Although r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700034/ https://www.ncbi.nlm.nih.gov/pubmed/31435460 http://dx.doi.org/10.4251/wjgo.v11.i8.579 |